Centuria Industrial REIT (ASX:CIP) 1H21 results & outlook
02 Feb 2021 - Centuria Industrial REIT (ASX:CIP) Fund Manager, Jesse Curtis talks 1H21 highlights, acquisitions, leasing activity and second half guidance.
02Feb
29Jan
Cyclopharm (ASX:CYC) raises $30M to support US expansion
29 Jan 2021 - Cyclopharm (ASX:CYC) CEO & Managing Director, James McBrayer talks about its recent cap raising to support rapid USA commercialisation for Technegas following USFDA approval targeted in Q2 2021.
27Jan
Immutep (ASX:IMM) company update on start of 2021
27 Jan 2021 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt analyses December's breast cancer data, and provides an update on efti's position and outlook.e sites.
20Jan
Retail trends under COVID, January 2021
20 Jan 2021 - National Retail Association CEO Dominique Lamb discusses retail performance over the Christmas period, trends in retail, and strategies for encouraging consumer spending.
18Jan
COVID-19 and Australian hotels
18 Jan 2021 - Tourism Accommodation Australia CEO Michael Johnson discusses the impact of COVID-19 on hotels across Australia.
15Jan
Jim Rogers predicts the next bear market will be the worst in over 70 years
15 Jan 2021 - Famed investor, author and market analyst Jim Rogers discusses the impact of the COVID-19 vaccine rollout, Chinese wine stocks, the bond bubble, why he is bullish on commodities, allegations of currency manipulation and how Aussie investors can get ahead.
12Jan
What the Democrats’ Senate win means for the market – the winners and the losers
12 Jan 2021 - OANDA Senior Market Analyst Craig Erlam discusses the recent Georgia Senate runoff and what control of the Senate and a Biden Presidency mean for equities; the vaccine rollout in Europe; the new Brexit deal; and the commodities market.
06Jan
Nyrada (ASX:NYR) discusses progress in cholesterol-lowering drug program, January 2021
06 Jan 2021 - Nyrada Limited (ASX:NYR) CEO James Bonnar discusses the cholesterol-lowering market, and recent results for the company's lead drug candidate, which achieved a 57% reduction in total cholesterol.
11Dec
Novatti Group (ASX:NOV) partners with Ripple
11 Dec 2020 - Novatti Group Limited (ASX:NOV) Managing Director Peter Cook discusses the company's strategy of partnering with Tier 1 companies, including Ripple, Google Pay and Samsung Pay.
11Dec
Cyclopharm (ASX:CYC) on pathway to US sales
11 Dec 2020 - Cyclopharm Limited (ASX:CYC) CEO & Managing Director James McBrayer talks about USFDA approval for Technegas, the company's USA commercialisation plan, and opportunities beyond its key diagnostic market for pulmonary embolism.